Lymphocyte toxicity test in clinical melanoma

Umberto Veronesi, Natale Cascinelli, Giuseppe Fossati, Silvana Canevari, Gianpaolo Balzarini

Research output: Contribution to journalArticle

Abstract

Between July 1970 and April 1972, peripheral lymphocytes of 35 patients with malignant melanoma were tested for in vitro cytotoxicity to autologous or homologous melanoma cells. Twenty-one cases (60%) had lymphocytes with a specific cytotoxic activity. No correlation was found with sex, age or clinical stage of the disease. To evaluate the prognostic significance of the in vitro cytotoxic activity of peripheral lymphocytes, 18 patients at stage I and II, who had been subjected to radical surgery prior to the cytotoxic test, were divided into two groups according to the result of the test (12 positives and 6 negatives) and were followed up for a maximum period of 32 months. Twelve cases had recurrence of the disease: 7 of the 12 cases with positive lymphocytes, and five of the 6 patients with negative lymphocytes. The difference between the two groups was not significant. The tumour-free interval has been 8·4 months in the seven cases with cytotoxic lymphocytes and 8 months in the 5 cases with no reactive ones.

Original languageEnglish
Pages (from-to)843-846
Number of pages4
JournalEuropean Journal of Cancer (1965)
Volume9
Issue number11-12
DOIs
Publication statusPublished - 1973

Fingerprint

Toxicity Tests
Melanoma
Lymphocytes
Recurrence
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Veronesi, U., Cascinelli, N., Fossati, G., Canevari, S., & Balzarini, G. (1973). Lymphocyte toxicity test in clinical melanoma. European Journal of Cancer (1965), 9(11-12), 843-846. https://doi.org/10.1016/0014-2964(73)90025-X

Lymphocyte toxicity test in clinical melanoma. / Veronesi, Umberto; Cascinelli, Natale; Fossati, Giuseppe; Canevari, Silvana; Balzarini, Gianpaolo.

In: European Journal of Cancer (1965), Vol. 9, No. 11-12, 1973, p. 843-846.

Research output: Contribution to journalArticle

Veronesi, U, Cascinelli, N, Fossati, G, Canevari, S & Balzarini, G 1973, 'Lymphocyte toxicity test in clinical melanoma', European Journal of Cancer (1965), vol. 9, no. 11-12, pp. 843-846. https://doi.org/10.1016/0014-2964(73)90025-X
Veronesi U, Cascinelli N, Fossati G, Canevari S, Balzarini G. Lymphocyte toxicity test in clinical melanoma. European Journal of Cancer (1965). 1973;9(11-12):843-846. https://doi.org/10.1016/0014-2964(73)90025-X
Veronesi, Umberto ; Cascinelli, Natale ; Fossati, Giuseppe ; Canevari, Silvana ; Balzarini, Gianpaolo. / Lymphocyte toxicity test in clinical melanoma. In: European Journal of Cancer (1965). 1973 ; Vol. 9, No. 11-12. pp. 843-846.
@article{7a4c4c7b1c844556a04b8441424294fb,
title = "Lymphocyte toxicity test in clinical melanoma",
abstract = "Between July 1970 and April 1972, peripheral lymphocytes of 35 patients with malignant melanoma were tested for in vitro cytotoxicity to autologous or homologous melanoma cells. Twenty-one cases (60{\%}) had lymphocytes with a specific cytotoxic activity. No correlation was found with sex, age or clinical stage of the disease. To evaluate the prognostic significance of the in vitro cytotoxic activity of peripheral lymphocytes, 18 patients at stage I and II, who had been subjected to radical surgery prior to the cytotoxic test, were divided into two groups according to the result of the test (12 positives and 6 negatives) and were followed up for a maximum period of 32 months. Twelve cases had recurrence of the disease: 7 of the 12 cases with positive lymphocytes, and five of the 6 patients with negative lymphocytes. The difference between the two groups was not significant. The tumour-free interval has been 8·4 months in the seven cases with cytotoxic lymphocytes and 8 months in the 5 cases with no reactive ones.",
author = "Umberto Veronesi and Natale Cascinelli and Giuseppe Fossati and Silvana Canevari and Gianpaolo Balzarini",
year = "1973",
doi = "10.1016/0014-2964(73)90025-X",
language = "English",
volume = "9",
pages = "843--846",
journal = "European Journal of Cancer",
issn = "0014-2964",
publisher = "Elsevier Ltd",
number = "11-12",

}

TY - JOUR

T1 - Lymphocyte toxicity test in clinical melanoma

AU - Veronesi, Umberto

AU - Cascinelli, Natale

AU - Fossati, Giuseppe

AU - Canevari, Silvana

AU - Balzarini, Gianpaolo

PY - 1973

Y1 - 1973

N2 - Between July 1970 and April 1972, peripheral lymphocytes of 35 patients with malignant melanoma were tested for in vitro cytotoxicity to autologous or homologous melanoma cells. Twenty-one cases (60%) had lymphocytes with a specific cytotoxic activity. No correlation was found with sex, age or clinical stage of the disease. To evaluate the prognostic significance of the in vitro cytotoxic activity of peripheral lymphocytes, 18 patients at stage I and II, who had been subjected to radical surgery prior to the cytotoxic test, were divided into two groups according to the result of the test (12 positives and 6 negatives) and were followed up for a maximum period of 32 months. Twelve cases had recurrence of the disease: 7 of the 12 cases with positive lymphocytes, and five of the 6 patients with negative lymphocytes. The difference between the two groups was not significant. The tumour-free interval has been 8·4 months in the seven cases with cytotoxic lymphocytes and 8 months in the 5 cases with no reactive ones.

AB - Between July 1970 and April 1972, peripheral lymphocytes of 35 patients with malignant melanoma were tested for in vitro cytotoxicity to autologous or homologous melanoma cells. Twenty-one cases (60%) had lymphocytes with a specific cytotoxic activity. No correlation was found with sex, age or clinical stage of the disease. To evaluate the prognostic significance of the in vitro cytotoxic activity of peripheral lymphocytes, 18 patients at stage I and II, who had been subjected to radical surgery prior to the cytotoxic test, were divided into two groups according to the result of the test (12 positives and 6 negatives) and were followed up for a maximum period of 32 months. Twelve cases had recurrence of the disease: 7 of the 12 cases with positive lymphocytes, and five of the 6 patients with negative lymphocytes. The difference between the two groups was not significant. The tumour-free interval has been 8·4 months in the seven cases with cytotoxic lymphocytes and 8 months in the 5 cases with no reactive ones.

UR - http://www.scopus.com/inward/record.url?scp=0015705476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015705476&partnerID=8YFLogxK

U2 - 10.1016/0014-2964(73)90025-X

DO - 10.1016/0014-2964(73)90025-X

M3 - Article

C2 - 4804311

AN - SCOPUS:0015705476

VL - 9

SP - 843

EP - 846

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0014-2964

IS - 11-12

ER -